Skip to content

Immune Characterization of Subcutaneous Adipose Tissue

Immune Characterization of Subcutaneous Adipose Tissue

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02076087
Acronym
ATI
Enrollment
19
Registered
2014-03-03
Start date
2014-02-28
Completion date
2017-09-30
Last updated
2017-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Determine Immune Cell Types in Subcutaneous Adipose Tissue

Keywords

Subcutaneous adipose tissue, Lipectomy

Brief summary

The overall goal of this proposal is to characterize the immune cell profile of subcutaneous abdominal adipose tissue in lean, overweight, obese and lipedema adults, and to evaluate potential associations between different adipose tissue immune cell types and metabolic profile.

Interventions

PROCEDURELiposuction/lipectomy

Subcutaneous adipose tissue will be obtained from liposuction/lipectomy to determine the types of immune cells

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Women of all races and ethnicity * Age between 18 and 65 years * Body Mass Index (BMI) ≥ 18.5 kg/m² * Weight stable (+/- 3% during the last 2 months before enrollment) * Women already scheduled for above mentioned procedures

Exclusion criteria

* Diabetes Mellitus * Recent (\<5 years) history of cancer (except in situ ductal breast carcinoma) * Chemotherapy and/or radiation therapy within 4 months before enrollment * Immune system diseases (i.e., autoimmune disorders, acquired immunodeficiency syndrome) * Pregnant or breastfeeding * Take any medication that might affect immune function * Severe organ dysfunction * BMI \<18.5 kg/m² or size of each breast is \>600 grams, if scheduled for bilateral breast reconstruction

Design outcomes

Primary

MeasureTime frame
Determine the types of immune cells and the relative prevalence of each type and sub-type, in subcutaneous adipose tissue of normal weight, overweight, obese and lipedema adults.intraoperative

Secondary

MeasureTime frame
Determine the relationships among specific types and subtypes of immune cells, adiposity and cardiometabolic risk.Baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026